Skip to main content
Top
Published in: Virology Journal 1/2013

Open Access 01-12-2013 | Research

Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae

Authors: Agata Kęsik-Szeloch, Zuzanna Drulis-Kawa, Beata Weber-Dąbrowska, Jerzy Kassner, Grażyna Majkowska-Skrobek, Daria Augustyniak, Marzanna Łusiak-Szelachowska, Maciej Żaczek, Andrzej Górski, Andrew M Kropinski

Published in: Virology Journal | Issue 1/2013

Login to get access

Abstract

Background

Members of the genus Klebsiella are among the leading microbial pathogens associated with nosocomial infection. The increased incidence of antimicrobial resistance in these species has propelled the need for alternate/combination therapeutic regimens to aid clinical treatment. Bacteriophage therapy forms one of these alternate strategies.

Methods

Electron microscopy, burst size, host range, sensitivity of phage particles to temperature, chloroform, pH, and restriction digestion of phage DNA were used to characterize Klebsiella phages.

Results and conclusions

Of the 32 isolated phages eight belonged to the family Myoviridae, eight to the Siphoviridae whilst the remaining 16 belonged to the Podoviridae. The host range of these phages was characterised against 254 clinical Enterobacteriaceae strains including multidrug resistant Klebsiella isolates producing extended-spectrum beta-lactamases (ESBLs). Based on their lytic potential, six of the phages were further characterised for burst size, physicochemical properties and sensitivity to restriction endonuclease digestion. In addition, five were fully sequenced. Multiple phage-encoded host resistance mechanisms were identified. The Siphoviridae phage genomes (KP16 and KP36) contained low numbers of host restriction sites similar to the strategy found in T7-like phages (KP32). In addition, phage KP36 encoded its own DNA adenine methyltransferase. The φKMV-like KP34 phage was sensitive to all endonucleases used in this study. Dam methylation of KP34 DNA was detected although this was in the absence of an identifiable phage encoded methyltransferase. The Myoviridae phages KP15 and KP27 both carried Dam and Dcm methyltransferase genes and other anti-restriction mechanisms elucidated in previous studies. No other anti-restriction mechanisms were found, e.g. atypical nucleotides (hmC or glucosyl hmC), although Myoviridae phage KP27 encodes an unknown anti-restriction mechanism that needs further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Abedon ST: Bacteriophage ecology. In Population growth, evolution, and impact of bacterial viruses. 1st edition. Edited by: Abedon ST. Cambridge, UK: Cambridge University Press; 2008.CrossRef Abedon ST: Bacteriophage ecology. In Population growth, evolution, and impact of bacterial viruses. 1st edition. Edited by: Abedon ST. Cambridge, UK: Cambridge University Press; 2008.CrossRef
2.
go back to reference Hemminga MA, Vos WL, Nazarov PV, Koehorst RB, Wolfs CJ, Spruijt RB, Stopar D: Viruses: incredible nanomachines. New advances with filamentous phages. Eur Biophys J 2010, 39: 541-550. 10.1007/s00249-009-0523-0PubMedPubMedCentralCrossRef Hemminga MA, Vos WL, Nazarov PV, Koehorst RB, Wolfs CJ, Spruijt RB, Stopar D: Viruses: incredible nanomachines. New advances with filamentous phages. Eur Biophys J 2010, 39: 541-550. 10.1007/s00249-009-0523-0PubMedPubMedCentralCrossRef
3.
go back to reference Łusiak-Szelachowska M, Weber-Dąbrowska B, Górski A: The presence of bacteriophages in human feces and their potential importance. Pol Merkur Lekarski 2006, 21: 381-383.PubMed Łusiak-Szelachowska M, Weber-Dąbrowska B, Górski A: The presence of bacteriophages in human feces and their potential importance. Pol Merkur Lekarski 2006, 21: 381-383.PubMed
5.
go back to reference Chibani-Chennoufi S, Bruttin A, Dillmann ML, Brüssow H: Phage-host interaction: an ecological perspective. J Bacteriol 2004, 186: 3677-3686. 10.1128/JB.186.12.3677-3686.2004PubMedPubMedCentralCrossRef Chibani-Chennoufi S, Bruttin A, Dillmann ML, Brüssow H: Phage-host interaction: an ecological perspective. J Bacteriol 2004, 186: 3677-3686. 10.1128/JB.186.12.3677-3686.2004PubMedPubMedCentralCrossRef
6.
go back to reference Shapiro OH, Kushmaro A: Bacteriophage ecology in environmental biotechnology processes. Curr Opin Biotechnol 2011, 22: 449-455. 10.1016/j.copbio.2011.01.012PubMedCrossRef Shapiro OH, Kushmaro A: Bacteriophage ecology in environmental biotechnology processes. Curr Opin Biotechnol 2011, 22: 449-455. 10.1016/j.copbio.2011.01.012PubMedCrossRef
7.
go back to reference Zaleski P, Wojciechowski M, Piekarowicz A: The role of Dam methylation in phase variation of haemophilus influenzae genes involved in defence against phage infection. Microbiology 2005, 151: 3361-3369. 10.1099/mic.0.28184-0PubMedCrossRef Zaleski P, Wojciechowski M, Piekarowicz A: The role of Dam methylation in phase variation of haemophilus influenzae genes involved in defence against phage infection. Microbiology 2005, 151: 3361-3369. 10.1099/mic.0.28184-0PubMedCrossRef
8.
go back to reference Kropinski AM: Measurement of the bacteriophage inactivation kinetics with purified receptors. Methods Mol Biol 2009, 501: 157-160. 10.1007/978-1-60327-164-6_16PubMedCrossRef Kropinski AM: Measurement of the bacteriophage inactivation kinetics with purified receptors. Methods Mol Biol 2009, 501: 157-160. 10.1007/978-1-60327-164-6_16PubMedCrossRef
9.
go back to reference Withey S, Cartmell E, Avery LM, Stephenson T: Bacteriophages – potential for application in wastewater treatment processes. Sci Total Environ 2005, 339: 1-18. 10.1016/j.scitotenv.2004.09.021PubMedCrossRef Withey S, Cartmell E, Avery LM, Stephenson T: Bacteriophages – potential for application in wastewater treatment processes. Sci Total Environ 2005, 339: 1-18. 10.1016/j.scitotenv.2004.09.021PubMedCrossRef
10.
go back to reference Donlan RM: Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 2009, 17: 66-72. 10.1016/j.tim.2008.11.002PubMedCrossRef Donlan RM: Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 2009, 17: 66-72. 10.1016/j.tim.2008.11.002PubMedCrossRef
11.
go back to reference Weinbauer MG: Ecology of prokaryotic viruses. FEMS Microbiol Rev 2004, 28: 127-181. 10.1016/j.femsre.2003.08.001PubMedCrossRef Weinbauer MG: Ecology of prokaryotic viruses. FEMS Microbiol Rev 2004, 28: 127-181. 10.1016/j.femsre.2003.08.001PubMedCrossRef
14.
go back to reference Labrie SJ, Samson JE, Moineau S: Bacteriophage Resistance mechanisms. Nat Rev Microbiol 2010, 8: 317-327. 10.1038/nrmicro2315PubMedCrossRef Labrie SJ, Samson JE, Moineau S: Bacteriophage Resistance mechanisms. Nat Rev Microbiol 2010, 8: 317-327. 10.1038/nrmicro2315PubMedCrossRef
15.
go back to reference Warren RAJ: Modified bases in bacteriophage DNAs. Annu Rev Microbiol 1980, 34: 137-158. 10.1146/annurev.mi.34.100180.001033PubMedCrossRef Warren RAJ: Modified bases in bacteriophage DNAs. Annu Rev Microbiol 1980, 34: 137-158. 10.1146/annurev.mi.34.100180.001033PubMedCrossRef
16.
go back to reference Kutateladze M, Adamia R: Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 2010, 28: 591-595. 10.1016/j.tibtech.2010.08.001PubMedCrossRef Kutateladze M, Adamia R: Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 2010, 28: 591-595. 10.1016/j.tibtech.2010.08.001PubMedCrossRef
18.
go back to reference Pappas G: An animal farm called extended-spectrum beta-lactamase: antimicrobial resistance as a zoonosis. Clin Microbiol Infect 2011, 17: 797-798. 10.1111/j.1469-0691.2011.03498.xPubMedCrossRef Pappas G: An animal farm called extended-spectrum beta-lactamase: antimicrobial resistance as a zoonosis. Clin Microbiol Infect 2011, 17: 797-798. 10.1111/j.1469-0691.2011.03498.xPubMedCrossRef
19.
go back to reference Carattoli A: Animal reservoirs for extended spectrum beta-lactamase producers. Clin Microbiol Infect 2008,14(Suppl 1):117-123. Erratum in: Clin Microbiol Infect 2008, 14 (Suppl 5):21–24PubMedCrossRef Carattoli A: Animal reservoirs for extended spectrum beta-lactamase producers. Clin Microbiol Infect 2008,14(Suppl 1):117-123. Erratum in: Clin Microbiol Infect 2008, 14 (Suppl 5):21–24PubMedCrossRef
20.
go back to reference Warren RE, Ensor VM, O’Neill P, Butler V, Taylor J, Nye K, Harvey M, Livermore DM, Woodford N, Hawkey PM: Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2008, 61: 504-508. 10.1093/jac/dkm517PubMedCrossRef Warren RE, Ensor VM, O’Neill P, Butler V, Taylor J, Nye K, Harvey M, Livermore DM, Woodford N, Hawkey PM: Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2008, 61: 504-508. 10.1093/jac/dkm517PubMedCrossRef
21.
go back to reference Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ, National ESBL surveillance group: Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011, 17: 873-880. 10.1111/j.1469-0691.2011.03497.xPubMedCrossRef Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ, National ESBL surveillance group: Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011, 17: 873-880. 10.1111/j.1469-0691.2011.03497.xPubMedCrossRef
22.
go back to reference Kropinski AM, Prangishvili D, Lavigne R: Position paper: the creation of a rational scheme for the nomenclature of viruses of bacteria and archaea . Environ Microbiol 2009, 11: 2775-2777. 10.1111/j.1462-2920.2009.01970.xPubMedCrossRef Kropinski AM, Prangishvili D, Lavigne R: Position paper: the creation of a rational scheme for the nomenclature of viruses of bacteria and archaea . Environ Microbiol 2009, 11: 2775-2777. 10.1111/j.1462-2920.2009.01970.xPubMedCrossRef
23.
go back to reference Ackermann HW: Classification of bacteriophages. In The bacteriophages. 2nd edition. Edited by: Calendar R. New York: Oxford University Press; 2006:8-16. Ackermann HW: Classification of bacteriophages. In The bacteriophages. 2nd edition. Edited by: Calendar R. New York: Oxford University Press; 2006:8-16.
24.
go back to reference Mehling JS, Lavender H, Clegg S: A Dam methylation mutant of Klebsiella pneumoniae is partially attenuated. FEMS Microbiol Lett 2007, 268: 187-193. 10.1111/j.1574-6968.2006.00581.xPubMedCrossRef Mehling JS, Lavender H, Clegg S: A Dam methylation mutant of Klebsiella pneumoniae is partially attenuated. FEMS Microbiol Lett 2007, 268: 187-193. 10.1111/j.1574-6968.2006.00581.xPubMedCrossRef
25.
go back to reference Römling U, Grothues D, Bautsch W, Tümmler B: A physical genome map of pseudomonas aeruginosa PAO. EMBO J 1989, 8: 4081-4089.PubMedPubMedCentral Römling U, Grothues D, Bautsch W, Tümmler B: A physical genome map of pseudomonas aeruginosa PAO. EMBO J 1989, 8: 4081-4089.PubMedPubMedCentral
26.
go back to reference Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X: A method for generation phage cocktail with great therapeutic potential. PLoS One 2012, 7: e31698. 10.1371/journal.pone.0031698PubMedPubMedCentralCrossRef Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X: A method for generation phage cocktail with great therapeutic potential. PLoS One 2012, 7: e31698. 10.1371/journal.pone.0031698PubMedPubMedCentralCrossRef
27.
go back to reference Kumari S, Harjai K, Chhibber S: Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Folia Microbiol (Praha) 2010, 55: 221-227. 10.1007/s12223-010-0032-7CrossRef Kumari S, Harjai K, Chhibber S: Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Folia Microbiol (Praha) 2010, 55: 221-227. 10.1007/s12223-010-0032-7CrossRef
28.
go back to reference Šimoliūnas E, Kaliniene L, Truncaite L, Klausa V, Zajančkauskaite A, Meškys R: Genome of klebsiella sp.-infecting bacteriophage vB_KleM_RaK2. J Virol 2012, 86: 5406. 10.1128/JVI.00347-12PubMedPubMedCentralCrossRef Šimoliūnas E, Kaliniene L, Truncaite L, Klausa V, Zajančkauskaite A, Meškys R: Genome of klebsiella sp.-infecting bacteriophage vB_KleM_RaK2. J Virol 2012, 86: 5406. 10.1128/JVI.00347-12PubMedPubMedCentralCrossRef
29.
go back to reference Verma V, Harjai K, Chhibber S: Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 2009, 59: 274-281. 10.1007/s00284-009-9430-yPubMedCrossRef Verma V, Harjai K, Chhibber S: Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 2009, 59: 274-281. 10.1007/s00284-009-9430-yPubMedCrossRef
30.
go back to reference Wu LT, Chang SY, Yen MR, Yang TC, Tseng YH: Characterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniae . Appl Environ Microbiol 2007, 73: 2532-2540. 10.1128/AEM.02113-06PubMedPubMedCentralCrossRef Wu LT, Chang SY, Yen MR, Yang TC, Tseng YH: Characterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniae . Appl Environ Microbiol 2007, 73: 2532-2540. 10.1128/AEM.02113-06PubMedPubMedCentralCrossRef
31.
go back to reference Hughes KA, Sutherland IW, Clark J, Jones MV: Bacteriophage and associated polysaccharide depolymerases – novel tools for study of bacterial biofilms. J Appl Microbiol 1998, 85: 583-590. Erratum in: J Appl Microbiol 1999, 86(2):359 10.1046/j.1365-2672.1998.853541.xPubMedCrossRef Hughes KA, Sutherland IW, Clark J, Jones MV: Bacteriophage and associated polysaccharide depolymerases – novel tools for study of bacterial biofilms. J Appl Microbiol 1998, 85: 583-590. Erratum in: J Appl Microbiol 1999, 86(2):359 10.1046/j.1365-2672.1998.853541.xPubMedCrossRef
32.
go back to reference Hausmann R, Gold M: The enzymatic methylation of ribonucleic acid and deoxyribonucleic acid. IX. Deoxyribonucleic acid methylase in bacteriophage-infected Escherichia coli . J Biol Chem 1966, 241: 1985-1994.PubMed Hausmann R, Gold M: The enzymatic methylation of ribonucleic acid and deoxyribonucleic acid. IX. Deoxyribonucleic acid methylase in bacteriophage-infected Escherichia coli . J Biol Chem 1966, 241: 1985-1994.PubMed
33.
go back to reference Auer B, Schweiger M: Evidence that Escherichia coli virus T1 induces a DNA methyltransferase. J Virol 1984, 49: 588-590.PubMedPubMedCentral Auer B, Schweiger M: Evidence that Escherichia coli virus T1 induces a DNA methyltransferase. J Virol 1984, 49: 588-590.PubMedPubMedCentral
34.
go back to reference Wagner EF, Auer B, Schweiger M: Development of Escherichia coli virus T1: escape from host restriction. J Virol 1979, 29: 1229-1231.PubMedPubMedCentral Wagner EF, Auer B, Schweiger M: Development of Escherichia coli virus T1: escape from host restriction. J Virol 1979, 29: 1229-1231.PubMedPubMedCentral
35.
go back to reference Hung CH, Kuo CF, Wang CH, Wu CM, Tsao N: Experimental phage therapy in treating Klebsiella pneumoniae -mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother 2011, 55: 1358-1365. 10.1128/AAC.01123-10PubMedPubMedCentralCrossRef Hung CH, Kuo CF, Wang CH, Wu CM, Tsao N: Experimental phage therapy in treating Klebsiella pneumoniae -mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother 2011, 55: 1358-1365. 10.1128/AAC.01123-10PubMedPubMedCentralCrossRef
36.
go back to reference Karamoddini MK, Fazli-Bazzaz BS, Emamipour F, Ghannad MS, Jahanshahi AR, Saed N, Sahebkar A: Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species. ScientificWorldJournal 2011, 11: 1332-1340.PubMedCrossRef Karamoddini MK, Fazli-Bazzaz BS, Emamipour F, Ghannad MS, Jahanshahi AR, Saed N, Sahebkar A: Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species. ScientificWorldJournal 2011, 11: 1332-1340.PubMedCrossRef
37.
go back to reference Kumari S, Harjai K, Chhibber S: Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae . J Microbiol Biotechnol 2009, 19: 622-628.PubMed Kumari S, Harjai K, Chhibber S: Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae . J Microbiol Biotechnol 2009, 19: 622-628.PubMed
38.
go back to reference Kumari S, Harjai K, Chhibber S: Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. J Microbiol Biotechnol 2010, 20: 935-941. 10.4014/jmb.0909.09010PubMedCrossRef Kumari S, Harjai K, Chhibber S: Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. J Microbiol Biotechnol 2010, 20: 935-941. 10.4014/jmb.0909.09010PubMedCrossRef
39.
go back to reference Kumari S, Harjai K, Chhibber S: Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol 2011, 60: 205-210. 10.1099/jmm.0.018580-0PubMedCrossRef Kumari S, Harjai K, Chhibber S: Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol 2011, 60: 205-210. 10.1099/jmm.0.018580-0PubMedCrossRef
40.
go back to reference Gill JJ, Hyman P: Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 2010, 11: 2-14. 10.2174/138920110790725311PubMedCrossRef Gill JJ, Hyman P: Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 2010, 11: 2-14. 10.2174/138920110790725311PubMedCrossRef
41.
go back to reference Jończyk E, Kłak M, Międzybrodzki R, Górski A: The influence of external factors on bacteriophages – review. Folia Microbiol (Praha) 2011, 56: 191-200. 10.1007/s12223-011-0039-8CrossRef Jończyk E, Kłak M, Międzybrodzki R, Górski A: The influence of external factors on bacteriophages – review. Folia Microbiol (Praha) 2011, 56: 191-200. 10.1007/s12223-011-0039-8CrossRef
42.
go back to reference Ryan EM, Gorman SP, Donnelly RF, Gilmore BF: Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol 2011, 63: 1253-1264. 10.1111/j.2042-7158.2011.01324.xPubMedCrossRef Ryan EM, Gorman SP, Donnelly RF, Gilmore BF: Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol 2011, 63: 1253-1264. 10.1111/j.2042-7158.2011.01324.xPubMedCrossRef
43.
go back to reference Leclerc H, Edberg S, Pierzo V, Delattre JM: Bacteriophages as indicators of enteric viruses and public health risk in groundwaters. J Appl Microbiol 2000, 88: 5-21.PubMedCrossRef Leclerc H, Edberg S, Pierzo V, Delattre JM: Bacteriophages as indicators of enteric viruses and public health risk in groundwaters. J Appl Microbiol 2000, 88: 5-21.PubMedCrossRef
44.
go back to reference Adams MH: Bacteriophages. New York: Interscience Publishers, Inc.; 1959. Adams MH: Bacteriophages. New York: Interscience Publishers, Inc.; 1959.
45.
go back to reference Ślopek S, Durlakowa I, Kucharewicz-Krukowska A, Krzywy T, Ślopek A, Weber B: Phage typing of shigella flexneri . Arch Immunol Ther Exp (Warsz) 1972, 20: 1-60. Ślopek S, Durlakowa I, Kucharewicz-Krukowska A, Krzywy T, Ślopek A, Weber B: Phage typing of shigella flexneri . Arch Immunol Ther Exp (Warsz) 1972, 20: 1-60.
46.
go back to reference Kutter E: Phage host range and efficiency of plating. In Bacteriophages: methods And protocols. Volume 1: isolation, characterization, and interactions. 1st edition. Edited by: Clokie MRJ, Kropinski AM. New York: Humana Press; 2009:141-149. Kutter E: Phage host range and efficiency of plating. In Bacteriophages: methods And protocols. Volume 1: isolation, characterization, and interactions. 1st edition. Edited by: Clokie MRJ, Kropinski AM. New York: Humana Press; 2009:141-149.
47.
go back to reference Gallet R, Shao Y, Wang IN: High adsorption rate is detrimental to bacteriophage fitness in a Biofilm-like environment. BMC Evol Biol 2009, 9: 241-253. 10.1186/1471-2148-9-241PubMedPubMedCentralCrossRef Gallet R, Shao Y, Wang IN: High adsorption rate is detrimental to bacteriophage fitness in a Biofilm-like environment. BMC Evol Biol 2009, 9: 241-253. 10.1186/1471-2148-9-241PubMedPubMedCentralCrossRef
48.
go back to reference Pajunen M, Kiljunen S, Skurnik M: Bacteriophage φYeO3-12, specific for yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J Bacteriol 2000, 182: 5114-5120. 10.1128/JB.182.18.5114-5120.2000PubMedPubMedCentralCrossRef Pajunen M, Kiljunen S, Skurnik M: Bacteriophage φYeO3-12, specific for yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J Bacteriol 2000, 182: 5114-5120. 10.1128/JB.182.18.5114-5120.2000PubMedPubMedCentralCrossRef
Metadata
Title
Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae
Authors
Agata Kęsik-Szeloch
Zuzanna Drulis-Kawa
Beata Weber-Dąbrowska
Jerzy Kassner
Grażyna Majkowska-Skrobek
Daria Augustyniak
Marzanna Łusiak-Szelachowska
Maciej Żaczek
Andrzej Górski
Andrew M Kropinski
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2013
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-10-100

Other articles of this Issue 1/2013

Virology Journal 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.